WELLS FARGO & COMPANY/MN - ABVC BIOPHARMA INC ownership

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ABVC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$67
-14.1%
129
+5.7%
0.00%
Q1 2023$78
+4.0%
122
+1.7%
0.00%
Q4 2022$75120
+3.4%
0.00%
Q3 2022$01160.00%
Other shareholders
ABVC BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,092,745$1,158,0000.02%
VANGUARD GROUP INC 375,142$398,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 49,915$52,0000.00%
BlackRock Inc. 39,042$41,0000.00%
Tower Research Capital LLC (TRC) 5,997$6,0000.00%
View complete list of ABVC BIOPHARMA INC shareholders